Cargando…
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Autores principales: | Zhang, Zhuangzhuang, Cheng, Lijun, Zhang, Qiongsi, Kong, Yifan, He, Daheng, Li, Kunyu, Rea, Matthew, Wang, Jianlin, Wang, Ruixin, Liu, Jinghui, Li, Zhiguo, Yuan, Chongli, Liu, Enze, Fondufe‐Mittendorf, Yvonne N., Li, Lang, Wang, Chi, Liu, Xiaoqi, Han, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284184/ https://www.ncbi.nlm.nih.gov/pubmed/35837804 http://dx.doi.org/10.1002/advs.202202572 |
Ejemplares similares
-
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
por: Zhang, Zhuangzhuang, et al.
Publicado: (2021) -
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling
por: Li, Chaohao, et al.
Publicado: (2023) -
Genome-wide DNA methylation reprogramming in response to inorganic arsenic links inhibition of CTCF binding, DNMT expression and cellular transformation
por: Rea, Matthew, et al.
Publicado: (2017) -
The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023) -
Epigenetics in prostate cancer treatment
por: Jones, Katelyn, et al.
Publicado: (2021)